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INTRODUCTION
The Ultrasonography Section of the Polish Society of 
Gynecologists and Obstetricians and Obstetrics is an or-
ganization promoting the development of ultrasound pre-
natal diagnostics and supporting the education of doctors 
and patients. The aim of the update of existing Guidelines 
from 2015 is to organize and indicate the optimal scheme 
of performing ultrasound examinations in uncomplicated 
pregnancies [1].
These updated Guidelines are in accordance with the 
Standards of international organizations such as the Inter-
national Society of Ultrasound in Obstetrics and Gynecol-
ogy (ISUOG 2010, 2013, 2016, 2019), the American College 
of Obstetricians and Gynecologists (ACOG) and the Fetal 
Medicine Foundation (FMF 2013, 2016, 2019).
Ultrasound examination is an essential diagnostic tool 
during pregnancy. According to the Standards of the Polish 
Society of Gynecologists and Obstetricians for uncompli-
cated pregnancy management, this test should be offered 
to all pregnant women, at least four times during pregnancy. 
The purpose of the examination is different depending on 
the stage of pregnancy.
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What is the purpose of an ultrasound 
examination?
The primary goal of ultrasound evaluation during preg-
nancy is to minimize the occurrence of unfavorable obstetric 
outcomes that may result from undiagnosed congenital 
defect in the fetus, fetal immaturity or other intrauterine 
complications. The task of the doctor performing ultrasound 
screening is to refer the pregnant woman to a referral center 
in every case of diagnostic doubts or suspected abnormal 
fetal development.
At each stage of fetal development, the ultrasound 
scan has different scope. The purpose of the examination 
is different in the first trimester of pregnancy as opposed 
to the second and third trimesters. The post-delivery term 
examination is also characterized by certain differences. Re-
gardless of the period of pregnancy during which the test 
is performed, the doctor should present the pregnant 
woman undergoing the test with a written result of the 
test with data enabling the identification of both the person 
under examination and the investigator and a summary 
with detailed elements of fetal anatomy which have been 
assessed and biometric measurements. The printout of the 
ultrasound image is not the result of the examination, but 
only supplementary documentation which may be part of 
the results. The patient should also receive comprehensive 
information about the results.
Who should receive an ultrasound examination?
In accordance with current legislation, ultrasound-based 
screening should be offered to all pregnant women. Re-
fusal by the patient to undergo the examination should 
be documented, in writing, preferably with the pregnant 
woman’s signature.
Is ultrasound examination safe?
At present, there are no study results suggesting that 
ultrasonography has an adverse effect on fetal development. 
When performing this examination, it is necessary to follow 
the principle of minimal exposure and time of examination 
to complete the procedure — ALARA (As Low As Reason-
ably Achievable). In particular, the values of thermal (TI) and 
mechanical (MI) indexes should be below 1, during the entire 
study (TI < 1, MI < 1). The safety principles of ultrasound ex-
amination are described in detail in separate publications [2].
What are the ultrasound equipment 
requirements?
Ultrasound for gynecological diagnostics should have 
the following capabilities: 2D real time, at least 128-step 
grey scale image, capacity to measure distance (at least 
two dimensions), circumference and surface area and ob-
stetric software. Additionally, they should be equipped with 
transabdominal and transvaginal transducers with capacity 
to print and store images.
What should an ultrasound results include?
An ultrasound examination results should present the 
following data:
a) patient’s first and last name, date of birth and Personal 
Identification Number (PESEL),
b) place and date of examination, first and last name of 
the examiner,
c) Information regarding the name of the ultrasound and 
the type and frequency of the transducers used
d) initial diagnosis written by the referring physician, if not 
a routine examination
e) date of last menstrual period and gestational age based 
on last menstrual period
f ) If it is difficult to determine the date of last menstrual 
period, the gestational age should be determined by 
the crown-rump length (CRL) in the first trimester. In 
the absence of testing in the first trimester of the preg-
nancy, the gestational age is determined based on HC 
measured in the second trimester of pregnancy.
g) The examining doctor information which should consist 
of a stamp and his/her signature
It should be clearly stated that any deviation from the 
normal condition of the fetus, the pelvic organ/uterus and 
any other abnormal symptoms diagnosed during the ex-
amination should also be included in the description of 
the examination. Oral communication of such information 
is not acceptable without an appropriate note in the result.
If a complete examination cannot be performed it 
should be noted in the examination result, and guidelines 
should be given on how to proceed and whether a further 
examination is planned. Elements which were unable or 
incomplete to visualize should be marked in the examina-
tion results. If a complete examination cannot be carried 
out or there insurmountable technical constraints during 
pregnancy affecting the quality of the ultrasound examina-
tion (e.g. due to the pregnant woman’s being overweight 
or obese, defects of the uterus, retroverted uterus, uterine 
fibroids etc.), this fact should be noted in the examination 
result, and guidelines should be given on how to proceed 
and whether a further examination is planned.
When informing pregnant woman/parents about the 
result of the ultrasound examination, attention should be 
paid to the limitations of this method and the impossibility 
of excluding all anatomical defects.
ULTRASOUND EXAMINATION BEFORE 10 
WEEKS OF GESTATION
The ultrasound examination during this period of preg-
nancy should be performed with a transvaginal transducer. This 
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examination is not mandatory, and we perform it on medical 
indications. The purpose of the ultrasound examination before 
10 weeks of pregnancy, performed on medical indications, is:
a) image and location of the fertilized egg — confirma-
tion of the presence of an intrauterine pregnancy or 
confirmation of a pregnancy with an unknown location. 
Special attention should be paid to the location of 
the gestational sac in patients after Caesarean sections 
due to the risk of pregnancy implantation in the scar 
after hysterotomy [3–5]. In case of any doubts in this 
respect, the patient should be referred for examination 
at the referral center.
b) Assessment of gestational age — based on fetal 
crown-rump length measurement (CRL)
c) Assessment of the presence of the gestational sac 
— measurement of the gestational sac (GS - mean of 
3 dimensions), position in the uterine cavity, number 
of gestational sacs. Until the embryo is visualized and 
until CRL measurement, with GS values above 20 mm 
and absent embryo there is a high risk of miscarriage.
d) Assessment of trophoblast echostructure for tropho-
blastic disease in the case of subjective hypertrophy of 
a chorionic echostructure typical in molar pregnancy 
(numerous small and disseminated hypoechogenic 
fields in the chorionic area), serum level of β-hCG 
determination should be ordered and the pregnant 
woman should be referred to hospital.
e) Assessment of the number of embryos, chorions and 
amnions — note: in case of a multiple pregnancy, the 
chorionicity and amnionicity should be determined by 
assessing the visibility of two separate or one common 
gestational sac.
f) Assessment of the yolk sac (YS) — presence of the YS 
(yes/no), description of possible YS irregularities. Note: 
If GS is present in the absence of YS or the embryo, 
attention should be paid to the possibility of ectopic 
pregnancy (pseudogestational sac).
g) Assessment of the presence of the embryo — pres-
ence (yes/no), CRL measurement, presence of the FHR 
(with CRL over 4 mm). Note: Using the transvaginal trans-
ducer, the FHR is visible with CRL ≥ 4 mm. In case of 
absent FHR with CRL< 5mm — the examination should 
be repeated to confirm the proper development of preg-
nancy.
h) Using the Doppler technique in the examination be-
fore 10 weeks of pregnancy, including for FHR  
assessment, is not recommended. It is preferred that 
FHR is shown in 2D (the so-called B presentation) or 
M-mode. The presence of bradycardia below 80 beats 
per minute increases the risk of miscarriage.
i) Evaluation of the genital organs of the pregnant 
woman — uterus together with the cervix (regular, ir-
regular shape), anatomy (normal, abnormal – defects, 
myomas). We assess the outline and presence of focal 
lesions, i.e. mainly myomas in terms of their location and 
relationship with the trophoblast. Differential diagnosis 
of congenital defects of the uterus during pregnancy is 
limited, but the focus should be on the possible pres-
ence of a septate uterus (the septum has a myometrial 
echostructure and remains in continuity with the uterine 
wall), a double uterus and a unicornuate uterus with 
a residual horn. In contrast, the chorionic strands which 
do not pose a threat to the development of the fetus are 
hyperechoic and remain in continuity with the tropho-
blast. The assessment of the cervix should include the 
possible presence of focal lesions such as myomas or the 
proliferative process (irregular focal lesions with uneven 
contours most often hypoechogenic with increased 
vascularization). The assessment of appendages for fo-
cal changes should be based on the system of simple 
rules, according to the terminology of the IOTA group. 
The examination technique is described in detail in rec-
ommendations for gynecological ultrasounds. Note: 
Abnormal masses in appendages should be described. 
If there are uterine myomas, describe their location and 
take measurements. The recto-uterine pouch should be 
examined for the presence of free fluid. The thickness 
of the fluid layer should be measured at cervical level 
following a perpendicular measurement line, the value 
of the measurement above 10 mm should be recorded 
in the result of the test. If there is no deviation from the 
standard, a detailed description is not necessary, but 
a statement is sufficient, for example: “uterus and ap-
pendages without pathological changes”.
ULTRASOUND EXAMINATION BETWEEN  
11+0–13+6 WEEKS OF PREGNANCY  
(CRL BETWEEN 45–84 MM)
The ultrasound examination performed at this stage of 
pregnancy involves several assumptions. The doctor pro-
viding prenatal care is obliged to explain to the patient the 
validity of these examinations. Each patient has the right 
to receive information about the possibility of performing 
prenatal tests. Such an obligation is imposed by Art. 38. Point 
3 of the Code of Medical Ethics, which states: “A doctor is 
obliged to inform patients with the possibilities of modern 
medical genetics, prenatal diagnosis and therapy.” In some 
Patients, these tests may be reimbursed by the National 
Health Fund (NFZ) within the framework of the Prenatal 
Screening Program, provided that the Patients meet the 
criteria for inclusion in the program.
The primary objective is to assess the anatomical struc-
tures of the fetus, to search for early structural defects and 
to assess the size of the fetus and determine the duration 
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of pregnancy, the date of birth, if this has not been done 
reliably at an earlier stage. Due to the technological de-
velopment of ultrasound and the related high resolution 
and precision of imaging, ultrasound examination between 
11 + 0–13 + 6 allows to suspect an increasing number of 
fetal defects [6–8]. We now estimate that the detection of 
abnormalities of the fetal anatomy in the first trimester is 
about 60% [9–11]. If early anatomical defects of the fetus 
are diagnosed, early prenatal invasive diagnostics can be 
offered to the pregnant woman to exclude the genetic 
disorders. The absolute prerequisite for reliable prenatal 
examination is to obtain ultrasound cross sections images 
in accordance with the standards and to obtain the best 
available images under given examination conditions. In 
connection with the introduction into clinical practice of 
cell-free fetal DNA in maternal blood (cffDNA) for screening 
for chromosome aberrations, in selected clinical situations 
it is recommended to suggest this diagnostic method to 
the pregnant woman. The evaluation of cell-free fetal DNA 
in maternal blood is recommended (only if there are no 
anatomical abnormalities in ultrasound examination) for 
pregnant women of the indirect risk group of trisomy 21, 
18, 13 (1:300–1:1000) [12]. If an abnormal prenatal screening 
result, structural defect in the fetus or abnormal values of 
nuchal translucency (above 95th percentile) are found, the 
pregnant woman should be referred for further evaluation at 
the referral center with the genetic consultation [13]. Due to 
the increase in the number of Caesarean sections in Poland 
(42.2% according to the Euro-Peristat 2015 report), more 
frequent complications occur in subsequent pregnancies in 
the form of implantation of a pregnancy in a scar after Cae-
sarean section and as a result of trophoblast growth [14–16].
Therefore, if the trophoblast is located on the anterior 
wall of the uterus, it is recommended to accurately assess 
the site of hysterotomy. In cases of doubts and suspicion 
of trophoblast growth in the scar after Caesarean section, 
the pregnant woman should be immediately referred to 
the reference center.
In other cases, at this stage of pregnancy we do not 
assess the location of the trophoblast, and it is particularly 
unjustified to make a diagnosis or suspicion of extremally 
low-lying trophoblast.
A detailed assessment of the structure of the fertilized 
egg includes the following elements (abdominal or trans-
vaginal transducer):
a) number of gestational sacs and fetuses in the uterine 
cavity
b) fetal heart rate evaluation (FHR)
Note: during normal pregnancy, the fetal heart rate de-
creases from about 170 beats per minute at 11 weeks of 
pregnancy to about 150 beats per minute at 14 weeks.
c) biometrics
CRL — crown-rump length measurement — assess-
ment/verification of gestational age when CRL< 84 mm. 
Note: every effort must be made to ensure that the 
CRL is measured reliably and precisely, because this is 
the basis for determining the age of the fetus and the 
date of delivery. CRL measurement should be taken 
when the fetus is in a neutral position and on its back, 
in the sagittal section. The value of 45 mm corresponds 
to 11 weeks + 0 days (according to some nomograms 
11 weeks + 2 days) and 84 mm – 13 weeks + 6 days 
(14 + 1 respectively)
d) fetal anatomy assessment [18–21]
•	 skull — shape, cerebral falx, plexuses, proportions 
of the choroid plexuses and cerebrospinal fluid in 
the fetal skull
•	 facial skeleton — we recommend assessing the pro-
file and presence of eyeballs if possible
•	 abdominal walls — umbilical cord insertion visibil-
ity position of the stomach - on the left under the 
diaphragm
•	 fetal heart — location, axis and heart rate; if possible, 
it is good clinical practice to visualize 4 cardiac cham-
bers and a cross-section through the transverse part 
of the ductal and aortic arches (expected V sign) 
mapped with colored Doppler.
•	 bladder in the sagittal projection (in some normal 
pregnancies it may be difficult to see)
•	 upper and lower limbs — tri-segmental assessment
•	 assessment of the chorion, description of possible 
irregularities
•	 chorionicity assessment in multiple pregnancy 
(LAMBDA or T sign)
The second goal of ultrasound examination at 
11 + 0 – 13 + 6 weeks of pregnancy is to assess the risk of 
the most common chromosome aberrations (trisomy 21, 18, 
13) [1]. The risk calculation is based on the history, maternal 
age, assessment of ultrasound and biochemical markers and 
should be performed using FMF-certified calculators only.
We recommend providing two risk values: background, 
which takes into account the age of the pregnant woman and 
a final result which evaluates all used ultrasound markers 
and biochemical parameters. It is a mistake to provide the 
patient with two separate results: the first one based on 
ultrasound examination alone, and the second one based 
on the ultrasound and biochemical markers.
In case of blood sampling for biochemical test on the 
day of ultrasound, the patient should be given a preliminary 
result of the examination without the risk of genetic defects 
(evaluation of gestational age, evaluation of fetal anatomy).
The final result of the examination with the genetic 
risk assessment should only be given after the biochemi-
cal test result.
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Ultrasound markers include the following basic mark-
ers [17]:
a) FHR — Fetal Heart Rate
b) NT — Nuchal Translucency.
Principles of assessing fetal NT according to FMF [18, 22]:
a) Image magnification — the head and 1/3 of the fetal 
chest occupy the entire screen.
b) Neutral fetal head position — no excessive bending 
in either direction of the fetal head.
c) Fetus position — fetal sagittal section.
Note: The sagittal section is obtained by showing the 
tip of the nose, nasal bone, nasal skin, hypoechogenic 
mesencephalon and a rectangular image of the fetal jaw.
d) Amniotic membrane — if it is visible, it must be dis-
tinguished from the skin of the fetus. Note: To obtain 
a contrasting NT and amniotic membrane image, reduce 
the gain to low values.
e) NT measurement — at the widest point, markers “inner 
to inner”, horizontal arms of markers placed on the NT 
limiting lines.
Note: If the umbilical cord runs around the neck of the 
fetus, it is recommended to first assess the anatomy of 
the fetus counting on the change of the fetus position. 
If this is not possible, it is possible to measure above 
and below the course of the umbilical cord and note 
the mean value, avoiding the use of such expressions 
as “umbilical cord around the neck” in the description.
The risk assessment of fetal chromosome aberrations 
should be performed between 11 + 0 – 13 + 6 (at 45–84 mm 
CRL). Mother’s age, history, NT and FHR in combination with 
biochemical markers (PAPP-A, free beta-hCG subunit) are 
components of the so-called combined test, also known as 
FTS (First Trimester Screening) [1, 22, 23]. Biochemical test 
which includes at least two of the above-mentioned elements 
is an indispensable element of a correct risk calculation.
A risk assessment without biochemical markers is an in-
correct practice and such a result should be considered as 
incomplete.
It is not appropriate to replace a biochemical test with 
a free fetal DNA test, as biochemical markers are not only 
used to assess the risk of trisomy.
Biochemical tests of the first trimester should be performed 
only on FMF-certified machines (Delfia, Kryptor, Roche).
The optimal time to collect blood for biochemical tests 
in the first trimester is 10–11 weeks of pregnancy.
Evaluation of the blood sample should be performed 
no later than 13 + 6 weeks of pregnancy (CRL — 84 mm).
In the case of abnormal values of collected biochemical 
markers, they should not be re-tasted unless an error is sus-
pected in the collection, storage or transport of the sample.
Evaluation of additional ultrasound markers of chromo-
some aberrations [23–25]:
•	 NB — Nasal Bone
•	 Note: we don’t measure nasal length in the first trimester 
of pregnancy. It is evaluated as: present, absent (hypoplas-
tic) or not assessable (under difficult technical conditions).
•	 DV PIV — Ductus Venosus, PIV)
•	 TR — Tricuspid Regurgitation
Assessment of additional markers increases the Detec-
tion Rate (DR) for trisomy 21 chromosome to 95%, with False 
Positive Rate (FPR) at 2.5%.
A physician with appropriate audits and an FMF license 
to assess additional markers (NB, TR, DV PIV) and a Polish 
Society of Gynecologists and Obstetricians — Ultrasound 
Section certificate can use additional markers to calculate 
the risk of genetic defects.
Invasive diagnostics (chorionic biopsy, genetic amnio-
centesis) should be recommended for pregnant women, 
who after performing the combined test (pregnant woman’s 
age, FHR, NT, PAPP-A, free beta-hCG), have a risk of chromo-
some aberrations in the fetus ≥ 1:300.
In the light of recent reports, the additional risk of preg-
nancy loss (adjusted for specific risk groups) and indications 
for amniocentesis) after the amniocentesis is about 0.1% [26].
During the first trimester of pregnancy, it is good clinical 
practice to try to exclude the occurrence of major ultrasound 
markers of chromosome abnormalities [27].
•	 hernia of the anterior abdominal wall (omphalocele)
•	 common atrioventricular canal,
•	 megacystis,
•	 congenital diaphragmatic hernia,
•	 holoprosencephaly, 
If they are present, regardless of other markers, the risk 
of chromosome aberrations in the fetus increases and 
the pregnant woman should be referred to a referral 
center for further examination and invasive diagnostics.
A referral to an invasive procedure (chorionic biopsy, 
amniocentesis, cordocentesis) may be issued by an obstetri-
cian-gynecologist or a perinatologist. Genetic consultation is 
not necessary to perform an invasive procedure (but it is recom-
mended especially in the case of genetic disease family history).
Ultrasound examination between 11 + 0–13 + 6 also 
provides the possibility of achieving the third aim of calcu-
lating the risk of pre-eclampsia PE [28–30].
Specialists with appropriate FMF certification can per-
form an extended examination PE risk calculation based 
on patient history, arterial pressure (MAP), uterine arterial 
pulsation index (Ut PI), placental growth factor (PlGF) con-
centration in pregnant blood serum [31].
If PlGF measurement cannot be used, PAPP-A values 
below 0.4 MoM suggest an increased risk of pre-eclampsia.
The ASPRE study in pregnant women examined the 
risk of PE preeclampsia using the FMF algorithm between 
11 + 0–13 + 6 weeks of pregnancy.
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In the high-risk group > 1:100 administration of acetyl-
salicylic acid (150 mg/day, from 11–14 weeks of pregnancy) 
reduced the incidence of PE < 37 weeks by 62% (p = 0.004) 
and PE < 34 weeks by 82% [32].
If a high risk is identified (currently the most common 
cut-off points are > 1:100 or > 1:150), prophylaxis with 
150 mg of acetylsalicylic acid (once a day before sleep) 
introduced after risk evaluation (week 11–14) and before 
16 weeks of pregnancy and continued until 36 weeks is 
recommended [32].
Each result of the ultrasound examination performed in 
the first trimester of pregnancy should be completed with 
a commentary and possible recommendations for further 
treatment for the referring doctor and the Patient.
ULTRASOUND EXAMINATION IN PREGNANCY 
WEEKS 18–22 AND 28–32 —  
FETAL DEVELOPMENT ASSESSMENT
The aim of an ultrasound examination in weeks 18–22 of 
pregnancy is a detailed assessment of the fetal organs in 
terms of congenital defects (assessment of the fetal ana-
tomical structure). Weeks 28–32 examination entails first 
and foremost the assessment of fetal growth and possibly 
fetal wellbeing assessment is particular clinical situations. In 
addition, the examinations are to determine the approxi-
mate fetal weight and gestational age (in case the date of 
last menstrual period is not known and/or no ultrasound 
was performed in the first trimester of pregnancy), based 
on biometric parameters. It is worth noting that both the 
multitude and individual variability of parameters (BPD, HC, 
AC, FL, HL, TCD) on the basis of which the gestational age 
can be determined, causes that the accuracy of this method, 
during this period of pregnancy, may be incorrect. In the 
first half of the second trimester (14–20 weeks), on the basis 
of the measurement of HC and the cerebellar transverse 
dimension, the gestational age can be estimated with an ac-
curacy of ± 7, ± 10 days. In the third trimester of pregnancy, 
the average spread of the estimated gestational age (mul-
tiparameter evaluation) is ± 3 weeks — in such situations 
HC or TCD is recommended to be used for the evaluation of 
the progress of pregnancy in the third trimester.
It should also be added that if the gestational age had 
previously been defined based on the CRL in the first trimes-
ter of pregnancy, no correction should be made for that age 
based on biometric measurements carried out in the second 
and third trimesters of pregnancy to adjust the date of birth.
1. Biometry, determination of estimated 
fetal weight and gestational age
measurement based on biometric parameters: 
BPD – Bi-Parietal Diameter, 
HC – Head Circumference, 
AC - Abdominal Circumference, 
FL – Femur Length, 
optionally HL - Humerus Length 
and TCD — Transverse Cerebellar Diameter [1, 33].
Bi-parietal diameter (BPD) — the transthalamic plane 
(recommended)
a) cross-section at the height of the thalami,
b) insonation angle 90°,
c) symmetric hemispheres and calvaria, the cerebellar 
hemispheres should not be in the plane of the image
d) midline falx with the cavum septi pellucidi.
Note: The calipers should be set according to the refer-
ence method used (usually “outer to inner” edge if the 
calvaria wall). In the transventricular plane, it is rec-
ommended to measure the width of the brain’s lateral 
ventricles.
Brain structures visible in particular planes:
Transthalamic plane: anterior horns of the lateral ven-
tricles, CSP, thalami, hippocampus
Transventricular: parallel to the plane described above, 
anterior and posteriori horns of the lateral ventricles, CSP.
Transcerebellar: anterior horns of the lateral ventricles, 
cavum septum pellucidum (CPS). thalami, cerebellum, cis-
terna magna.
Fetal head circumference (HC) — measurement plane 
analogous to BPD measurement.
Note: use an ellipse, covering the outer outline of the 
fetal skull.
Abdominal circumference (AC) — measurement plane:
a) cross section in the transverse plane,
b) umbilical vein at the hepatic sinus level,
c) visible gastric bubble, invisible kidneys.
Note: Use an ellipse, covering the external contour of 
the fetal abdomen.
Femur length (FL) — measurement plane:
a) Measurement in the longest axis,
b) Insonation angle 45–90°.
Note: The markers should be placed on the farthest ends 
of the bone, excluding cartilage if visible.
Fetal humerus length (HL) — measurement plane:
a) measurement in the longest axis,
b) Insonation angle 45–90°.
Note: The markers should be placed at the farthest ends 
of the bone, not including cartilage if visible
2. Evaluation of fetal structures and organs  
— evaluation of fetal anatomy [1, 33–35]
Table I presents the recommended minimum values 
of fetal anatomy during ultrasound examination between 
18–22 weeks of pregnancy.
a) Skull —evaluation of 4 features:
•	 Size — assessment when measuring BPD, HC.
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•	 Shape — oval, no loss of continuity - except for 
cranial sutures. Abnormal shape (lemon, strawberry, 
clover leaves) should be documented.
•	 Continuity — no bone defects, no external visible 
brain structures.
•	 Echogenicity — homogeneous, only cavities at 
the cranial sutures. The "excessively" visible brain 
structures of a fetus may show defects in bone min-
eralization (e.g. hypophosphatasia, osteogenesis 
imperfecta), similarly to the susceptibility of the 
skull to transducer compression through maternal 
abdominal walls [36].
b) Fetal central nervous system — assessment in at 
least three planes allowing for visualization of the CNS 
— transventricular, transthalamic and transcerebellar 
(posterior fossa).
The following should be visualized: lateral ventricles with 
choroid plexuses, cavum septum pellucidum, cerebral 
falx, thalami, cerebellum and cistern magna. The pos-
terior horn of the lateral ventricle should be measured.
c)  Fetal face — the assessment should include the evalu-
ation of the upper lip (assessment of the presence of 
cleft), alveolar process of the jaw, eyeballs, face profile, 
visibility and measurement of nasal bone.
d) Fetal neck — assessment of the presence of possible 
tumors. The assessment includes examination for lesions 
such as the cystic hygroma or teratoma in this area and 
measurement of NF — Nuchal Fold in 18–22 weeks of 
pregnancy.


















alveolar process of the jaw
Skeleton
Spine - no defects
(axial, sagittal and coronal plane)
Upper and lower limbs — tri-segmental
Neck Lack of tumors (cystic hygroma, neck teratoma) Placenta PositionPossible abnormalities
Chest/Heart
Shape of the chest
Size, position and axis of the heart
Heart rate,
4 chamber view
Outflow track from the heart ventricles
3-vessel view
3-vessel-trachea view
Umbilical cord Number of vessels, insertion
Gender Female of male*
*optional, depending on examination conditions and patient’s wish
Table 2. Recommended range of fetal heart rate screening [1]
Minimum evaluation parameters have been bolded
FETAL HEART SCREENING performed by an obstetrician-
gynecologist
•	 Determination of the sides of the fetus based on its position 
in the uterus
•	 Visualization of the stomach
•	 Visualization of the aorta descending to the front and left of the 
fetal spine
•	 Visualization of the inferior vena cava forward of the aorta and to 
the right of the fetal spine
•	 Visibility of the heart in the chest
•	 Heart size - the area of the heart is about 1/3 of the chest area
•	 Visualization of the heart on the left side of the chest
•	 Determination of heart axis — 45° ± 20°
•	 No pericardial fluid
•	 Assessment of the heart rate — preferably in the left ventricle 
in a four-chamber projection at the ventricular septum at 
the border of inflow and outflow, which gives the possibility 
to additionally determine if there is no atrial to ventricular 
impulse conduction disturbance - (normal sinus rhythm 110–
160 beats/min)
•	 Visualization of the 4 cardiac chambers (4CHV) with a cross 
of the heart
•	 Visualization of 3 vessels in the upper mediastinum (3V) 
— pulmonary trunk, aorta, upper vena cava
•	 Visualization of 3 vessels and trachea in the upper mediastinum 
(3VT) — trachea to the right of the aortic arch and ductal arch
•	 Visualization of the outflow tracts from the chambers:
•	 LVOT — the left ventricular outflow tract is not divided, septal-
vascular continuity is maintained
•	 RVOT — the right ventricular outflow tract is divided into 
branches: right and left pulmonary artery and ductus arteriosus
•	 Visualization of the crossing of Ao and PA after leaving the 
respective chambers
4CHV (4 Chamber View), 3VV (3 Vessel View), 3VTV (3-Vessel-Trachea View), 
LVOT (Left Ventricle Outflow Tract), RVOT (Right Ventricle Outflow Tract)
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e) Fetal chest — regular shape, without deformities, both 
lungs of homogeneous echogenicity, without patho-
logical masses, fluid reservoirs and mediastinal displace-
ment. Hypoechogenic diaphragm line visible on the 
sagittal section.
f) Fetal heart — it is recommended that the fetal heart 
image is magnified so it occupies 1/3 of the image.
g) Fetal abdomen — the position of internal organs in 
relation to the heart apex should be assessed:
•	 Fetal stomach on the left side, position and shape 
abnormalities (e.g. double bubble image) should 
be documented.
•	 Bowels should be located in the abdomen. Signs 
of bowel loop dilatation should be documented.
•	 Cord insertion should form a picture of the letter T 
with the abdominal wall. The cord insertion should 
be examined for any disturbances in the anterior 
abdominal wall (umbilical hernia, gastroschisis). The 
number of vessels in the umbilical cord should be 
determined, preferably by doppler ultrasonogra-
phy, showing the course of the umbilical arteries 
along the fetal urinary bladder or on the transverse 
section. The presence of a single umbilical artery 
should be an indication for a thorough reassess-
ment of the fetal anatomy or further diagnosis at 
the referral center.
•	 Fetal gallbladder is not part of a routine evaluation 
in the 2nd and 3rd trimester
•	 Both kidneys should be visualized, the expansion 
of the pelvicalyceal system should be documented 
(measurement of AP or PA on the transverse sec-
tion). The measurement of the renal pelvis should 
be performed on the transversal section of the fetal 
abdomen at the height of the fetal kidneys with the 
fetal spine at 6 or 12 o’clock. A measurement above 
7 mm should be considered as an indication for 
verification at the referral center.
•	 Fetal urinary bladder should be visualized, magni-
fication and abnormal shape should be documented 
(e.g. “keyhole” image — posterior urethral valve).
•	 Fetal spine — assessment in the sagittal, axial and 
coronal planes with assessment of skin continuity. 
Spina bifida is often accompanied by changes in the 
fetal CNS anatomy (cerebellum — banana sign, col-
lapsed cisterna magna). Other measurement planes 
may be helpful in detecting deformations e.g. of the 
vertebrae or sacral agenesis.
h) Fetal limbs — minimum evaluation involves three-seg-
mental view of the fetal limbs. It is not recommended 
to count fingers and toes.
i) Placenta evaluation — the minimum evaluation in-
cludes determining the position of the placenta and 
the relation to the cervical internal os in the sagittal 
projection. Abnormalities in the placenta structure 
— hematomas, tumors and other pathological masses 
should be documented. Pregnant women after uter-
ine procedures or with a low-lying placenta should be 
referred for a follow-up placenta accreta examination. 
In cases of doubts, the placenta should be reassessed, 
or the patient should be referred to a higher reference 
center to evaluate for PAS (placenta accreta spectrum) 
— the currently recommended term for placental ac-
creta/increta/percreta.
j) Examination of the cervix, uterus, uterine append-
ages — During the second trimester ultrasound exami-
nation it is possible to assess the risk of preterm birth by 
measuring the length of the cervical canal.
k) In case the so-called “amniotic sludge” is found, this fact 
should be recorded in the result of the examination. Any 
abnormal masses within the cervix or adnexa should 
be documented if they may constitute an obstacle to 
delivery.
l) Evaluation of amniotic fluid — may be performed 
subjectively or using semi-quantitative indicators (AFI, 
MVP, DP). Pregnant women with abnormal amounts of 
amniotic fluid should receive a detailed fetal evaluation 
at a reference center.
m) Fetal gender evaluation — may be performed upon 
request and after the parents’ consent. If there are any 
changes of the nature of e.g. testicular hygroma, ovar-
ian cyst or clitoral hypertrophy, this should be included 
in the test description.
n) In the 3rd trimester examination during pregnancy, the 
assessment of blood flow in the umbilical artery, mid-
dle cerebral artery or uterine arteries is not routinely 
performed. However, it may be performed if the ex-
amining physician, who is qualified to do so, considers 
this examination to be clinically justified and is able to 
interpret the results.
V. FETAL ULTRASOUND EXAMINATION AFTER 
DELIVERY DATE
After 280 days of pregnancy, the risk of intrauterine fetal 
death is greater, especially in cases of fetuses with previously 
undiagnosed growth restriction (SGA) [37]. According to the 
current recommendations, after delivery date, each patient 
should have an ultrasound examination, which primary 
goal is [38]:
1. Evaluation of the fetal position and presentation,
2. Evaluation of fetal heart activity and beats per minute,
3. Biometry and determination of the estimated fetal 
weight — if the stage of delivery makes it possible 
and since the last evaluation was more than 7 days 
ago. Measurement based on the following biometric 
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Table 3. Ultrasound examination report form in 18–22 and 28–32 weeks of pregnancy
First name, Surname:…………..……................................
Date of birth:………………………..………..............
PESEL (Personal Identification Number) ......................................…












Lateral ventricles, Vp standard up to 10 mm
Cerebellum





FETAL BIOMETRY Upper lip and lower lip
Parameter mm week Alveolar process of the jaw
BPD NECK, NF standard up to 6 mm
HC HEART




Fetal weight (g) 3-vessel-trachea view
PLACENTA:
Position (wall).....………………………………….





AMNIOTIC FLUID (volume) 
□ normal □ abnormal 





□ normal □ absent
Abdominal cord insertion
Number of cord vessels □ 2 □ 3
SKELETON
FETAL LIE
□ longitudinal □ cephalic □ breech






COMMENT: GENDER (optional) □ M □ Ż
RECOMMENDATIONS:
CONCLUSIONS:
□ normal and complete exam result
□ normal but incomplete exam result
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parameters: BPD — Bi-Parietal Diameter, HC — Head 
Circumference, AC — Abdominal Circumference, and 
FL — Femur Length using the Hadlock equations to 
estimate fetal weight,
4. Assessment of the volume of amniotic fluid (AFI or MVP),
5. Assessment of the position of the placenta and its rela-
tion to the internal cervical os,
6. In justified cases — further evaluation including the fetal 
biophysical profile (BPS, Manning test) and/or umbili-
cal arterial Doppler and middle cerebral artery Doppler 
with qualitative assessment of the flow spectrum and 
semi-quantitative assessment, including determination of 
the PI - Pulsatility Index, with reference to reference values.
It should be emphasized that the ultrasound examina-
tion after the expected delivery date carries the highest 
risk of error. In the case of finding fetal presentation other 
than cephalic, too low or too high fetal weight, or reduced 
volume of amniotic fluid, it is necessary to refer the patient 
to an obstetric-gynecological hospital to plan the delivery.
ULTRASOUND EXAMINATION OF MULTIFETAL 
PREGNANCY
Multiple pregnancy cannot be considered a physiologi-
cal pregnancy and is associated with an increased risk of 
premature delivery, pre-eclampsia, complications related 
to fetal growth and death. For this reason, obstetric care for 
this type of pregnancy is usually provided in referral centers.
This type of pregnancy is diagnosed by ultrasound ex-
amination performed in the first trimester. During the exami-
nation, chorionicity and amnionicity (number of chorions 
and amnions) are determined. Assessment of chorionicity 
from the ultrasound examination shall be documented by 
a sonographic image
If the pregnant woman reports after the 14th week of 
pregnancy or if chorionicity cannot be determined and 
both fetuses are of the same sex, it should be treated as 
a monochorionic twin pregnancy.
The rules of ultrasound examination in a patient with 
a dichorionic twin pregnancy:
1. The diagnosis of a dichorionic pregnancy by ultrasound 
in the first trimester of pregnancy is based on the fol-
lowing findings: two separate sacs with embryos and 
a lambda sign;
2. ultrasound examination in multiple pregnancies should 
be performed:
a) in the first trimester of pregnancy (11–13 weeks + 
+ 6 days) — with an assessment of the risk of genetic 
defects for each fetus separately,
b) in the second trimester of pregnancy (18–22 weeks) 
— with evaluation of the anatomy of each fetus 
and with transvaginal measurement of the cervical 
length
c) in the third trimester of pregnancy examination 
should be performed in weeks 28, 32, 36 — to assess 
the growth of the fetuses (if a mass discrepancy is 
greater than or equal to 25% is found, the patient 
should be referred for care to a third degree perinatal 
care center),
d) before delivery — to determine fetal presentation;
The rules of ultrasound examination in a patient with 
a monochorionic twin pregnancy:
Due to the frequent occurrence of specific complications 
associated with fetal growth and the risk of fetal intrauterine 
death, the care of monochorionic twins must be performed 
at a third-degree level of perinatal care. In addition to ultra-
sound examinations, fetal echocardiography should always 
be ordered in this type of pregnancy.
1. care of a patient with monochorionic diamniotic preg-
nancy:
a) The diagnosis of a monochorionic diamniotic preg-
nancy results from an ultrasound examination in 
the first trimester finding a single gestational sac 
with two embryos and two amniotic sacs, with the 
insertion of the amniotic membrane separating the 
embryos to the chorion having the shape of the 
letter “T”,
b) ultrasound examination in a monochorionic diam-
niotic pregnancy should be performed: — in the 
first trimester of pregnancy (11–13 weeks + 6 days) 
— with an evaluation of the risk of genetic defects 
(the same for both fetuses) and fetal biometry,
c) from week 16 of pregnancy, every 2 weeks for the 
detection of TTTS or sIUGR, taking into account as-
sessment of: fetal biometry, volume of amniotic fluid 
in both sacs, symptom of free-floating intertwin 
membrane, filling of both fetal urinary bladders and 
vascular flows by Doppler (umbilical arteries, middle 
cerebral arteries, venous ducts).
In the case of complications, the frequency and scope 
of ultrasound examinations should be decided individually.
d) before delivery — to determine the biometrics and 
presentation of the fetuses;
2. care of a patient with monochorionic-monoamniotic 
twin pregnancy:
a) the diagnosis of a monochorionic-monoamniotic 
pregnancy is based on the finding of a single gesta-
tional sac with two closely spaced embryos and no 
embryo separating membrane in the first trimester 
of pregnancy; the absence of the separating mem-
brane should be confirmed in subsequent ultra-
sound examinations; it is also important to exclude 
the presence of conjoined twins,
b) ultrasound examinations in a monochorionic-mono-
amniotic pregnancy shall be performed: — in the 
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first trimester of pregnancy (11–13 weeks + 6 days), 
with an assessment of the risk of genetic abnormali-
ties (the same for both fetuses), exclusion of con-
joined twins and an assessment of cords insertion,
c) from the 16th week of pregnancy — every 2 weeks 
with the assessment of fetal growth and vascular 
flows by Doppler evaluation (umbilical arteries, 
middle cerebral arteries, venous ducts).
d) in the second trimester of pregnancy (18–22 weeks) 
— with evaluation of the anatomy of each fetus and 
transvaginal measurement of the cervical length,
e) in hospital conditions from the 26th week — with 
an assessment of the fetal hemodynamics: Doppler 
examination of vascular flows (umbilical arteries, 
middle cerebral arteries, venous ducts) — should 
be performed at least twice a week.
CONCLUSIONS
For the safety and the highest quality of services pro-
vided, the ultrasound examination should be performed by 
an individual with appropriate qualifications, confirmed by 
appropriate documents issued by national and international 
organizations and subjecting their results to periodic control 
and audit.
At the time of this update, the documents confirming 
the above skills and qualifications are: 
1. documents confirming the specialization in obstetrics 
and gynecology,
2. certificates issued by the Ultrasound Section of the Pol-
ish Society of Gynecologists and Obstetricians
•	 Basic certificate of the Ultrasound Section of the 
Polish Society of Gynecologists and Obstetricians,
•	 Certificate of Prenatal Screening of the Ultrasound 
Section of the Polish Society of Gynecologists and 
Obstetricians,
•	 Certificate of Fetal Heart Examination of the Ultra-
sound Section of the Polish Society of Gynecologists 
and Obstetricians,
3. Certificates issued by international organizations, i.e.:
•	 FMF certificate of competence in measurement of 
nuchal translucency (NT),
•	 FMF certificates in other ultrasound markers (NB, TR 
and DV and uterine artery),
•	 Diploma in Fetal Medicine — issued by FMF.
Since 2012, the Ultrasound Section of the Polish Society 
of Gynecologists and Obstetricians has been conducting 
courses and workshops, as well as theoretical and practical 
exams in order to select specialists in prenatal diagnosis and 
fetal echocardiography.
The Ultrasound Section of the Polish Society of Gynecol-
ogists and Obstetricians additionally recommends:
1. Conducting the examination in conditions that allow 
to the sonographer to concentrate (limited of the  
number of people present at the study, keeping silence 
in the office).
2. The presence of children in the examination room dur-
ing examination is not recommended
The rules described above also apply to the performance 
of ultrasound examinations according to the recommenda-
tions of the Polish Society of Gynecologists and Obstetri-
cians in the period between 11–14 weeks of pregnancy, 
18–22 weeks of pregnancy, 27–32 weeks of pregnancy, and 
immediately after week 40 referred to in the Annex to the 
Regulation of the Minister of Health of 16 August 2018 (item 
1756): Organisational Standard of Health Care for Entities 
Providing Perinatal Care Services [39].
The guidelines are accompanied by a guide containing 
images showing the normal scans obtained during ultra-
sound examination.
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